Effects of the anti-TNF-antibody infliximab on markers of bone turnover in patients with rheumatoid arthritis.

被引：0
|
作者：
Mueller, TJ
Hermann, J
Fahrleitner, A
Yazdani-Biuki, B
Dimai, HP
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1076
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [41] Biochemical Markers of Bone Turnover in Rheumatoid Arthritis Patients Treated with Glucocorticoids
    Macovei, Luana Andreea
    Burlui, Alexandra
    Rezus, Elena
    REVISTA DE CHIMIE, 2019, 70 (02): : 623 - 626
  • [42] Positive Effects of Tocilizumab On Bone Remodeling in Patients with Rheumatoid Arthritis.
    Briot, Karine
    Schaeverbeke, Thierry
    Etchepare, Fabien
    Gaudin, Philippe
    Perdriger, Aleth
    Vray, Muriel
    Rouanet, Stephanie
    Steinberg, Ghislaine
    Roux, Christian
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S358 - S358
  • [43] Influence of Infliximab on Cytokines Network and Markers of Bone Remodeling in Rheumatoid Arthritis Patients
    Korczowska, Izabela
    Lacki, Jan Krzysztof
    Hrycaj, Pawel
    YONSEI MEDICAL JOURNAL, 2013, 54 (01) : 183 - 188
  • [44] Long-term safety of infliximab (anti-TNFα antibody) in patients with rheumatoid arthritis:: Results of the attract trial
    Schaible, TF
    Braakman, T
    Marsters, P
    Harriman, G
    GASTROENTEROLOGY, 1999, 116 (04) : A813 - A813
  • [45] Effects of infliximab on bone turnover markers in patients with rheumatoid arthritis: Improvement of bone remodeling balance and differential effects on cathepsin K and matrix-metalloproteases mediated bone resorption.
    Thomas, T
    le Henanff, A
    Debiais, F
    Daragon, A
    Roux, C
    Sany, J
    Wendling, D
    Zarnitsky, C
    Ravaux, P
    Garnero, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S305 - S305
  • [46] Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis
    Kageyama, Yasunori
    Takahashi, Masaaki
    Torikai, Eiji
    Suzuki, Motohiro
    Ichikawa, Tetsuya
    Nagafusa, Tetsuyuki
    Koide, Yukio
    Nagano, Akira
    CLINICAL RHEUMATOLOGY, 2007, 26 (04) : 505 - 509
  • [47] Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis
    Yasunori Kageyama
    Masaaki Takahashi
    Eiji Torikai
    Motohiro Suzuki
    Tetsuya Ichikawa
    Tetsuyuki Nagafusa
    Yukio Koide
    Akira Nagano
    Clinical Rheumatology, 2007, 26 : 505 - 509
  • [48] Innflamatory process in rheumatoid arthritis and bone turnover markers
    Budlewski, Tomasz
    Pomorska, Ewa
    Makowska, Joanna Samanta
    ALERGIA ASTMA IMMUNOLOGIA, 2020, 25 (03): : 154 - 165
  • [49] Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
    Tetsuya Kaneko
    Koichi Okamura
    Yukio Yonemoto
    Chisa Okura
    Takahito Suto
    Masahiro Tachibana
    Hideo Sakane
    Makoto Inoue
    Hirotaka Chikuda
    Journal of Experimental Orthopaedics, 6
  • [50] Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
    Kaneko, Tetsuya
    Okamura, Koichi
    Yonemoto, Yukio
    Okura, Chisa
    Suto, Takahito
    Tachibana, Masahiro
    Sakane, Hideo
    Inoue, Makoto
    Chikuda, Hirotaka
    JOURNAL OF EXPERIMENTAL ORTHOPAEDICS, 2019, 6 (01)
12345